In Their Own Words: Health Care Providers - U.S. Food and Drug Administration (.gov)
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
My name is Amy Techau and I work in several health care settings. I am a nurse practitioner in rural community mental health settings. I teach and train physicians, nurse practitioners, and physician assistants how to prescribe medications for OUD at the University of Colorado. And I am responsible for evidence-based practices that decrease barriers to accessing MOUD. When diagnosing a patient with OUD. I use the DSM-5 criteria, but I am very much about meeting the patient where they're at. I ask questions without fear or judgment, about whether opioid use is having an impact on their social life, their work life, If they are having withdrawal, if they're having cravings. Oftentimes people are very grateful that you are asking those questions because they want help, but there is just so much stigma. All of my students and anyone that I'm supporting with this, I tell them to cast a wide net because it could be someone you least expect, someone that you even know. It could be the mom next door, or that senior who is taking it for pain and then just got a little out of control.
This article is an excerpt. To read the full content, visit the original source. U.S. Food and Drug Administration (.gov)
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!